Sun Pharma board to consider ₹15,000 crore NCD issue on 12 October
Sun Pharmaceutical Industries will hold a board meeting on 12 October to consider issuing non-convertible debentures worth up to ₹15,000 crore through private placement in one or more tranches, the company said…
